Chip giants TSMC (NYSE:TSM) and Broadcom (NASDAQ:AVGO) are exploring potential bids for Intel (NASDAQ:INTC), possibly splitting the semiconductor leader, according to the Wall Street Journal. TSMC is evaluating acquiring Intel's chip manufacturing plants, either independently or with a consortium. Broadcom is interested in Intel’s chip design and marketing units but would pursue a bid only if a partner for Intel’s foundry business is secured.
The discussions are in early stages, and Intel has not been approached. Both firms are acting independently. This speculation comes as Intel struggles to keep pace with rivals like AMD (NASDAQ:AMD), Nvidia (NASDAQ:NVDA), Qualcomm (NASDAQ:QCOM), and Broadcom in the AI-driven chip market. Intel's foundry business has consistently posted losses amid fierce competition from TSMC.
Intel recently started separating its foundry division, a move that could facilitate a split. The company remains the largest beneficiary of the U.S. CHIPS Act, receiving substantial federal funding. However, the involvement of the U.S. government, particularly the Trump administration, adds complexity, as foreign control over domestic chip facilities is unlikely to receive presidential approval.
The potential acquisition discussions follow Intel’s leadership turmoil, with CEO Pat Gelsinger ousted in December after failing to implement a successful turnaround. The company is currently seeking new leadership. This development underscores the increasing pressure on Intel as it navigates financial losses, leadership changes, and intensified competition in the semiconductor industry.


Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Elon Musk’s SpaceX Acquires xAI in Historic Deal Uniting Space and Artificial Intelligence
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Elon Musk’s Empire: SpaceX, Tesla, and xAI Merger Talks Spark Investor Debate
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 



